ArticleVaccine2021

Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial.

Cassandra Aldrich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.